Scarica l'app Stockscreener
117.25
2.84%
3.24
Dopo l'orario di chiusura:
117.25
Precedente Chiudi:
$114.01
Aprire:
$116.63
Volume 24 ore:
855.85K
Relative Volume:
1.01
Capitalizzazione di mercato:
$5.43B
Reddito:
-
Utile/perdita netta:
$-63.78M
Rapporto P/E:
-43.75
EPS:
-2.68
Flusso di cassa netto:
$-53.91M
1 W Prestazione:
+11.25%
1M Prestazione:
+14.67%
6M Prestazione:
+751.49%
1 anno Prestazione:
+933.04%
Intervallo 1D:
$114.20
$120.31
Intervallo di 1 settimana:
$103.00
$120.31
Portata 52W:
$7.575
$120.31
Celcuity Inc Stock (CELC) Company Profile
Nome
Celcuity Inc
Settore
Industria
Telefono
763-392-0767
Indirizzo
16305 36TH AVENUE N, MINNEAPOLIS, MN
Confronta CELC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
117.25 | 5.28B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | Wells Fargo | Overweight |
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-11-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | Iniziato | Guggenheim | Buy |
| 2025-07-01 | Ripresa | Stifel | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-02-22 | Iniziato | Stifel | Buy |
| 2023-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-07 | Iniziato | Jefferies | Buy |
| 2021-07-29 | Iniziato | Cowen | Outperform |
| 2021-07-27 | Iniziato | Needham | Buy |
| 2021-01-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-11 | Ripresa | Craig Hallum | Buy |
| 2018-11-20 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Celcuity Inc Borsa (CELC) Ultime notizie
Celcuity (NASDAQ:CELC) Reaches New 52-Week HighTime to Buy? - MarketBeat
Celcuity stock hits all-time high at 116.65 USD - Investing.com
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN
Celcuity, Inc. (NASDAQ:CELC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Celcuity Inc: A Die To Be Cast Before July 2026 (NASDAQ: CELC) - Seeking Alpha
Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - directorstalkinterviews.com
Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain - Yahoo Finance
(CELC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
FDA accepts Celcuity’s NDA for gedatolisib with priority review By Investing.com - Investing.com South Africa
Celcuity granted FDA priority review for breast cancer therapy - MSN
Celcuity wins FDA review for breast cancer drug (CELC:NASDAQ) - Seeking Alpha
FDA Accepts Celcuity's NDA For Gedatolisib In HR+, HER2- Advanced Breast Cancer - Nasdaq
FDA accepts Celcuity’s NDA for gedatolisib with priority review - Investing.com
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer - manilatimes.net
Short Interest in Celcuity, Inc. (NASDAQ:CELC) Expands By 20.9% - MarketBeat
Is Celcuity Inc. stock gaining market shareEarnings Growth Summary & Daily Profit Maximizing Trade Tips - bollywoodhelpline.com
Dow Update: Can POAI lead its sector in growth2025 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Merger Talk: Is Madison Square Garden Sports Corp stock forming a cup and handleJuly 2025 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Chart Watch: Can Celcuity Inc disrupt its industryJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Nisa Investment Advisors LLC Buys 14,930 Shares of Celcuity, Inc. $CELC - MarketBeat
Celcuity (NASDAQ:CELC) Shares Down 6.2%Should You Sell? - MarketBeat
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why - MSN
Celcuity stock reaches all-time high at 112.78 USD By Investing.com - Investing.com Nigeria
Celcuity (NASDAQ:CELC) Reaches New 1-Year HighStill a Buy? - MarketBeat
Celcuity stock reaches all-time high at 112.78 USD - Investing.com
Market Wrap: Can Celcuity Inc ride the EV waveJuly 2025 Closing Moves & Short-Term High Return Ideas - baoquankhu1.vn
Macro Review: Can Celcuity Inc. stock beat analyst upgrades2025 Volume Leaders & Growth-Oriented Investment Plans - Bộ Nội Vụ
The Bull Case For Celcuity (CELC) Could Change Following Shelf Registration And FDA Review ProgressLearn Why - simplywall.st
Celcuity (NASDAQ:CELC) Shares Gap DownHere's What Happened - MarketBeat
Wells Fargo initiates coverage on Celcuity Inc. (CELC) - MSN
Assessing Celcuity (CELC) Valuation After Wells Fargo Coverage And Key FDA NDA Review Progress - simplywall.st
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) - Finviz
Celcuity (CELC) surges 662% in 2025 on breast cancer treatment trial results - MSN
How (CELC) Movements Inform Risk Allocation Models - Stock Traders Daily
Risks Report: Is American National Group Inc stock attractive for long term wealth buildingMarket Sentiment Report & Trade Opportunity Analysis Reports - moha.gov.vn
Celcuity files for mixed shelf size not disclosedSEC filing - marketscreener.com
Celcuity Inc. (CELC) Investor Outlook: Analyzing the Biotechnology Stock with a $4.84 Billion Market Cap - DirectorsTalk Interviews
Why Celcuity Inc. stock is a value investor pickJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - Улправда
Can Celcuity Inc. stock beat analyst upgradesJuly 2025 Review & Precise Swing Trade Entry Alerts - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
Is Celcuity Inc. stock attractive after correction2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru
Gains Recap: Can Celcuity Inc stock sustain free cash flow growthMarket Sentiment Review & AI Enhanced Market Trend Forecasts - moha.gov.vn
What valuation multiples suggest for Celcuity Inc. stockMean Reversion Trades & Exceptional Profit Growth - ulpravda.ru
Celcuity initiated with an Outperform at Wolfe Research - MSN
Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase? - The Globe and Mail
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - MSN
Analysts Expect Breakeven For Celcuity Inc. (NASDAQ:CELC) Before Long - 富途牛牛
What analysts say about Celcuity Inc stockWeekly Market Snapshot & You’ll Thank Yourself in 6 Months - earlytimes.in
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results - Insider Monkey
Celcuity Inc Azioni (CELC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):